cocaine
Studies associated with:
| Division | Study Number | Title | Investigator(s) | Release Date |
|---|---|---|---|---|
| DTMC | NIDA-CPU-0010 | Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine | Louis Cantilena, Jr., M.D, Ph.D. | |
| DTMC | NIDA-CTO-0012 | Phase 2, Double-Blind, Placebo-Controlled Trial Of Tiagabine For The Treatment Of Cocaine Dependence | Eugene Somoza, M.D. | |
| DTMC | NIDA-CSP-1021 | Double-Blind, Placebo-Controlled Multi-Center Trial Of Baclofen For The Treatment Of Cocaine Dependence | Liza Gorgon, M.A. | |
| DTMC | NIDA-CSP-1019 | Double-Blind, Placebo-Controlled Trial Of Selegiline Transdermal System For The Treatment Of Cocaine Dependence | Ahmed Elkashef, M.D., Paul J. Fudala, Ph.D. | |
| DTMC | NIDA-MDS-0003 | Phase I, Double-Blind, Placebo-Controlled Assessment Of Potential Interactions Between Intravenous Cocaine And Ethanol And Oral Disulfiram | John D. Roache, Ph.D. | |
| DTMC | NIDA-CTO-0007 | Phase 2, Double-Blind, Placebo-Controlled Trial Of Cabergoline For The Treatment Of Cocaine Dependence | Steven Shoptaw, Ph.D., Thomas F. Newton, M.D. | |
| DTMC | NIDA-CPU-0005 | Double-blind, placebo-controlled, safety and pharmacology study with 75 mg dosage of GBR 12909 in cocaine experienced African American Volunteers. | Louis Cantilena, Jr., M.D, Ph.D. | |
| DTMC | NIDA-CPU-0004 | Study of Interactions Between GBR 12909 and Cocaine | Kathryn Cunningham, Ph.D., John Grabowski, Ph.D. | |
| DTMC | NIDA-CPU-0003 | Phase I, Double-Blind, Placebo-Controlled Dose Escalating Assessment of Potential Interactions Between Intravenous Cocaine and RPR 102681 | Louis Cantilena, Jr., M.D, Ph.D. | |
| DTMC | NIDA-CPU-0002 | Double-Blind, Placebo-Controlled, Dose Escalating, Safety and Pharmacology Study With Three Dosages of GBR 12909 in Cocaine Experienced Volunteers | Louis Cantilena, Jr., M.D, Ph.D. | |
| DTMC | NIDA-CTO-0006 | Cocaine-Metyrapone Interaction Study | Bonita Singal, M.D., T. John Winhusen, Ph.D. | |
| DTMC | NIDA-CTO-0005 | Double-Blind, Placebo-Controlled Trial Of Ondansetron For The Treatment Of Cocaine Dependence | John D. Roache, Ph.D. | |
| DTMC | NIDA-CTO-0003 | Assessment Of Potential Interactions Between Intravenous Cocaine And Tolcapone | Thomas F. Newton, M.D. | |
| DTMC | NIDA-CTO-0002 | Safety Evaluation Of Cocaine Treatment Medication, Modafinil: Interactions With Intravenous Cocaine | Robert J. Malcolm, M.D., C. Lindsay DeVane, Pharm.D. | |
| DTMC | NIDA-MDS-0004 | Phase 2, Double-Blind, Placebo-Controlled Trial Of Modafinil For The Treatment Of Cocaine Dependence | Domenic Ciraulo, M.D. | |
| DTMC | NIDA-CTO-0001 | Phase 2, Double-Blind, Placebo-Controlled Trial Of Reserpine For The Treatment Of Cocaine Dependence | Eugene Somoza, M.D. | |
| CTN | NIDA-CTN-0052 | A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence (BRAC) | T. John Winhusen, Ph.D. | |
| CTN | NIDA-CTN-0048 | Cocaine Use Reduction with Buprenorphine (CURB) | Walter Ling, M.D. |